Insider Trading March 30, 2026

IperionX President Purchases $262,552 in ADS as Coverage Begins and Production Ramps

Toby Edgcumbe Symonds buys 11,000 American Depository Shares amid analyst initiations and early commercial output at Virginia facility

By Caleb Monroe IPX
IperionX President Purchases $262,552 in ADS as Coverage Begins and Production Ramps
IPX

IperionX Ltd (NASDAQ: IPX) President Toby Edgcumbe Symonds purchased 11,000 American Depository Shares on March 27, 2026, for $23.8684 apiece, totaling $262,552. The trade comes while the stock trades near $23.15 and has fallen 53% over six months. Recent analyst initiations from BTIG and William Blair accompany the transaction as IperionX starts commercial production at its Virginia site.

Key Points

  • IperionX President Toby Edgcumbe Symonds bought 11,000 ADS on March 27, 2026, at $23.8684 per share for $262,552.
  • Following the transaction, Symonds directly holds 11,000 ADS, 3,188,146 Ordinary Shares, 703,199 RSUs, and Performance Rights for Ordinary Shares.
  • BTIG and William Blair initiated coverage - BTIG with a Buy and $40.00 price target citing commercial production at the Virginia facility (initially ~200 tpa, targeting ~1,400 tpa next year); William Blair initiated with an Outperform rating noting scaling potential in titanium powder and component manufacturing.

Insider purchase details

Toby Edgcumbe Symonds, President of IperionX Ltd (NASDAQ: IPX), acquired 11,000 American Depository Shares (ADS) on March 27, 2026. The shares were bought at a per-share price of $23.8684, producing a total transaction value of $262,552. Following the purchase, Symonds directly holds 11,000 ADS, 3,188,146 Ordinary Shares, and 703,199 Restricted Stock Units (RSUs). He also retains Performance Rights for Ordinary Shares.

Market context

The purchase was disclosed as IperionX shares were trading near $23.15, a level that reflects a 53% decline over the past six months. InvestingPro analysis referenced in company reports describes the stock as being in oversold territory, language that can indicate a potential buying opportunity—a dynamic the executive’s purchase appears to mirror.

Analyst coverage and production update

Two research firms have recently initiated coverage on IperionX. BTIG started coverage with a Buy rating and set a price target of $40.00. In its initiation notes, BTIG cited the company’s commencement of commercial production at its Virginia facility, expecting initial output of roughly 200 tonnes per annum with plans to scale to about 1,400 tonnes per annum next year.

William Blair also began coverage, assigning an Outperform rating. William Blair highlighted IperionX’s potential to scale operations to become the nation’s largest titanium powder producer, along with component manufacturing capabilities. These analyst actions and the production ramp are framed by the company’s stated aim to address rising demand in the titanium market.

Investor resources

For investors seeking additional detail on IperionX’s financial position and analyst insights, the company’s profile on InvestingPro offers extended analysis and a set of InvestingPro Tips for deeper examination.


Contextual note

The disclosed purchase and the analyst coverage reflect concurrent developments around company insider activity and the firm’s early-stage commercial production. The available information documents the transaction, shareholdings, market price movement, and newly initiated equity research coverage, along with projected production milestones from the Virginia site.

Risks

  • Share price decline - IPX has fallen 53% over the past six months, which may reflect volatility and market risk for investors.
  • Execution risk - The Virginia facility is at the early stage of commercial production with initial output around 200 tonnes per annum and plans to scale to about 1,400 tonnes per annum next year, creating operational ramp risks.
  • Concentration risk in industrial materials - Developments primarily impact the metals and materials supply chain and manufacturing sectors, which may face demand and pricing fluctuations.

More from Insider Trading

GlobalFoundries’ CLO Disposes of $22,995 in Stock as Company Faces Legal and Capital Moves Mar 30, 2026 Lemonade Director Increases Stake with $485k in Stock Purchases Mar 30, 2026 Neuronetics Insider Adds $675,000 in Shares as Company Reports Mixed Q4 Results Mar 30, 2026 Horace Mann CMO Makes Modest Stock Purchase as Company Posts Strong Q4 Results Mar 30, 2026 LightPath CEO Makes Small Personal Purchase as Company Posts Revenue Beat but EPS Misses Mar 30, 2026